Publication

CARDIOVASCULAR ENDOCRINOLOGY Dual RAAS blockade has dual effects on outcome

Heerspink, H. J. L. & de Zeeuw, D., May-2013, In : Nature reviews endocrinology. 9, 5, p. 261-263 4 p.

Research output: Contribution to journalEditorialAcademicpeer-review

Makani and colleagues report that dual blockade of the renin-angiotensin-aldosterone system is associated with harm despite previous studies showing that this approach decreases blood pressure and albuminuria. Do these results imply that we should abandon surrogate markers? Or should we become more creative in using them? Lambers Heerspink, H. J. & de Zeeuw, D. Nat. Rev. Endocrinol. 9, 261-263 (2013); published online 26 March 2013; doi:10.1038/nrendo.2013.65

Original languageEnglish
Pages (from-to)261-263
Number of pages4
JournalNature reviews endocrinology
Volume9
Issue number5
Publication statusPublished - May-2013

    Keywords

  • END-POINTS, TRIAL, RISK, TELMISARTAN, RAMIPRIL

ID: 5848011